畜禽养殖

Search documents
温氏股份发布上半年业绩,归母净利润34.75亿元,增长159.12%
Zhi Tong Cai Jing· 2025-08-27 16:12
Group 1: Financial Performance - The company reported a revenue of 49.852 billion yuan for the first half of 2025, representing a year-on-year increase of 5.91% [1] - The net profit attributable to shareholders was 3.475 billion yuan, showing a significant year-on-year growth of 159.12% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 3.256 billion yuan, up 137.63% year-on-year [1] - Basic earnings per share were 0.5252 yuan [1] Group 2: Pork Sales - The company sold 16.6166 million head of live pigs (including both live and fresh products), which is a year-on-year increase of 15.6% [1] - The average selling price of live pigs was 14.93 yuan per kilogram, a decrease of 2.56% year-on-year [1] - The sales revenue from pork products reached 32.735 billion yuan, reflecting a year-on-year increase of 16.26% [1] - The increase in pork sales revenue was primarily driven by the rise in sales volume [1] - The company experienced a significant reduction in breeding costs due to improved management and lower feed raw material prices, leading to a substantial increase in profits from pig farming [1] Group 3: Chicken Sales - The company sold 598 million live chickens (including live, fresh, and cooked products), marking a year-on-year growth of 9.16% [2] - The average selling price of live chickens was 10.84 yuan per kilogram, which represents a year-on-year decline of 18.43% [2] - The sales revenue from chicken products was 15.127 billion yuan, a decrease of 9.29% year-on-year, primarily due to the drop in selling prices [2]
温氏股份(300498.SZ)发布上半年业绩,归母净利润34.75亿元,增长159.12%
智通财经网· 2025-08-27 16:10
Group 1: Financial Performance - The company reported a revenue of 49.852 billion yuan for the first half of 2025, representing a year-on-year increase of 5.91% [1] - The net profit attributable to shareholders was 3.475 billion yuan, showing a significant year-on-year growth of 159.12% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 3.256 billion yuan, up 137.63% year-on-year [1] - Basic earnings per share were 0.5252 yuan [1] Group 2: Pork Sales - The company sold 16.6166 million head of live pigs, an increase of 15.6% year-on-year [1] - The average selling price of live pigs was 14.93 yuan per kilogram, a decrease of 2.56% year-on-year [1] - Revenue from pork sales reached 32.735 billion yuan, reflecting a year-on-year increase of 16.26% [1] - The increase in pork sales revenue was primarily driven by the rise in sales volume [1] - The company experienced a significant reduction in breeding costs due to improved management and lower feed raw material prices, leading to a substantial increase in profits from pig farming [1] Group 3: Chicken Sales - The company sold 598 million live chickens, marking a year-on-year growth of 9.16% [2] - The average selling price of live chickens was 10.84 yuan per kilogram, down 18.43% year-on-year [2] - Revenue from chicken sales was 15.127 billion yuan, a decline of 9.29% year-on-year, primarily due to the decrease in selling prices [2]
温氏股份(300498.SZ):上半年净利润34.7亿元 同比增长159.12%
Ge Long Hui A P P· 2025-08-27 15:05
Core Insights - The company reported a total revenue of 49.875 billion yuan for the first half of the year, representing a year-on-year increase of 5.92% [1] - The net profit attributable to shareholders reached 3.47 billion yuan, showing a significant year-on-year growth of 159.12% [1] - The company's asset-liability ratio decreased to 50.57%, indicating continuous optimization of its asset structure [1] Production Performance - The production of livestock and poultry remained stable, with a pig market release rate of 93% and a chicken market release rate of 95.1% [1] - The sales volume of pigs and chickens increased year-on-year, with 16.6166 million pigs and 598 million chickens sold, reflecting growth rates of 15.6% and 9.16% respectively [1]
温氏股份(300498.SZ):上半年净利润34.75亿元 同比增长159.12%
Ge Long Hui A P P· 2025-08-27 15:05
Core Viewpoint - The company reported a significant increase in both revenue and net profit for the first half of 2025, indicating strong financial performance and growth potential in the market [1] Financial Performance - The company achieved an operating revenue of 49.852 billion yuan, representing a year-on-year growth of 5.91% [1] - The net profit attributable to shareholders reached 3.475 billion yuan, showing a remarkable year-on-year increase of 159.12% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 3.256 billion yuan, reflecting a year-on-year growth of 137.63% [1] - The basic earnings per share were reported at 0.5252 yuan [1]
8月27日重要资讯一览
Zheng Quan Shi Bao Wang· 2025-08-27 13:33
Group 1 - In July, profits of medium and small enterprises in the industrial sector improved, with medium-sized enterprises' profits growing by 1.8% and small enterprises' profits growing by 0.5%, reversing declines of 7.8% and 9.7% in June respectively [2] - Private enterprises saw a profit increase of 2.6% in July, outperforming the average profit growth of all large-scale industrial enterprises by 4.1 percentage points [2] - High-tech manufacturing profits experienced rapid growth in July, indicating a significant leading role in the industrial sector [2] Group 2 - The Ministry of Commerce announced upcoming policies to promote service exports and expand service consumption [2] - The Ministry of Industry and Information Technology issued guidelines to optimize business access and promote the development of the satellite communication industry, aiming for over 10 million satellite communication users by 2030 [2] - Jilin Province will implement a tax refund policy for overseas travelers starting September 1, 2025 [2] Group 3 - The Jiangsu Provincial Government and the Ministry of Commerce released a plan to support the biopharmaceutical industry, emphasizing financial support for innovative enterprises through various financing methods [3] - The plan encourages the establishment of investment funds for the biopharmaceutical sector and supports the issuance of real estate investment trusts (REITs) for qualifying projects [3] - Shanghai's government issued opinions to accelerate the renovation of urban villages, prioritizing areas with urgent community needs and safety concerns [3] Group 4 - Meituan reported a revenue of 91.8 billion yuan for the second quarter, reflecting a year-on-year growth of 11.7% [5] - Cambridge Technology's major shareholder reduced their stake by 1.8 million shares through block trading [5] - Jack Shares plans to change its stock name to "Jack Technology" and is expected to release a high-end AI sewing machine in the second half of the year [5] - Debang Lighting intends to acquire at least 51% of Jiali Shares, which is expected to constitute a major asset restructuring [5] - Honghe Technology reported a net profit of 87.3751 million yuan for the first half of the year, marking a year-on-year increase of 10,587.74% [5] - Wens Foodstuff Group achieved a net profit of 3.475 billion yuan in the first half of the year, a year-on-year increase of 159.12% [5] - Five Grains Liquid reported a net profit of 19.492 billion yuan for the first half of the year, reflecting a year-on-year growth of 2.28% [5]
温氏股份最新公告:上半年净利润34.7亿元 同比增长159.12%
Sou Hu Cai Jing· 2025-08-27 13:02
以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 温氏股份(300498.SZ)公告称,上半年实现营业收入498.52亿元,同比增长5.91%。归属于上市公司股东 的净利润为34.75亿元,同比增长159.12%。同时,公司计划不派发现金红利,不送红股,不以公积金转 增股本。 ...
温氏股份:上半年净利润34.75亿元 同比增长159.12%
Zheng Quan Shi Bao Wang· 2025-08-27 12:45
人民财讯8月27日电,温氏股份(300498)8月27日晚间发布半年报,2025年上半年,公司实现营业收入 498.52亿元,同比增长5.91%;归母净利润34.75亿元,同比增长159.12%;基本每股收益0.5252元。报告 期内,公司肉猪类销售收入327.35亿元,同比增长16.26%。肉猪类收入增长原因主要是销售量增加。同 时,报告期内,公司持续推进精细化管理,大生产整体稳定,叠加饲料原料价格下降的影响,公司养殖 成本同比呈较大幅度下降。因此,公司生猪养殖业务利润同比呈较大幅度上升。 ...
温氏股份:上半年净利同比增长159.12%
Di Yi Cai Jing· 2025-08-27 12:43
Core Insights - The company reported a total operating revenue of 49.852 billion yuan for the first half of the year, representing a year-on-year increase of 5.91% [2] - The net profit attributable to the parent company's shareholders reached 3.475 billion yuan, showing a significant year-on-year growth of 159.12% [2] - Basic earnings per share were 0.5252 yuan, reflecting a year-on-year increase of 159.36% [2] Q2 Performance - In the second quarter, the operating revenue was 25.534 billion yuan, which is a year-on-year increase of 1.21% [2] - The net profit attributable to the parent company's shareholders for Q2 was 1.473 billion yuan, indicating a year-on-year decrease of 42.83% [2]
温氏股份:上半年归母净利润34.75亿元,同比增长159.12%
Xin Lang Cai Jing· 2025-08-27 12:42
温氏股份8月27日披露半年报,公司上半年实现营业收入498.52亿元,同比增长5.91%;归属于上市公司 股东的净利润34.75亿元,同比增长159.12%;基本每股收益0.5252元。公司计划不派发现金红利,不送 红股,不以公积金转增股本。 ...
傲农生物: 福建傲农生物科技集团股份有限公司股票交易异常波动公告
Zheng Quan Zhi Xing· 2025-08-27 10:16
Core Viewpoint - The stock of Fujian Aonong Biological Technology Group Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative price deviation exceeding 20% over three consecutive trading days in August 2025 [1][2]. Group 1: Stock Trading Abnormality - The company's stock price increased by more than 20% cumulatively on August 25, 26, and 27, 2025, which is classified as an abnormal trading fluctuation according to the Shanghai Stock Exchange regulations [1][2]. - The company conducted a self-examination and confirmed that there are no undisclosed significant matters or information that could impact the stock price [1][2]. Group 2: Operational Status - The company reported that its production and operational status is normal, with no significant changes in its main business activities [1][2]. Group 3: Major Events and Market Influence - There are no undisclosed major events that could significantly affect the stock price, such as major asset restructuring, share issuance, or significant business collaborations [2]. - The company has not identified any media reports or market rumors that could have a substantial impact on its stock price [2]. Group 4: Insider Trading - The company confirmed that there were no stock trades by its controlling shareholders or senior management during the period of abnormal stock price fluctuation [2]. Group 5: Board Statement - The board of directors affirmed that there are no undisclosed matters that should be reported according to the Shanghai Stock Exchange listing rules, and previous disclosures do not require correction or supplementation [2].